Personalized medicine in the context of The Human Chemical Sciences Institute refers to the relationship between genetic differences among individuals and corresponding differences in their chemical state and how they respond to various nutrients, drugs, and compounds in their environment.
Here too lies an opportunity to develop a new point of view that derives from the interface of chemistry and medicine and yields biomarkers that can be monitored in the clinical setting to evaluate disease risk, response to therapy, and other critical health outcomes.
Daniel Salomon, M.D.
|Dan Roden, M.D.
Assistant Vice Chancellor for Personalized Medicine
Vanderbilt University Medical Center